Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia.
Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia.
复制标题
增殖优势而非经典耐药性是慢性粒细胞白血病治疗失败的原因。
DOI：
10.3109/10428199309047903
复制
发表时间：
1993
影响因子：
2.6
通讯作者：
Baccarani,M
中科院分区：
文献类型：
--
作者：
Preisler,HD;Raza,A;Baccarani,M
